Abstract:A bstract Among virtual screening methods that have been developed to facilitate the drug discovery process, chemogenomics presents the particularity to tackle the question of predicting ligands for proteins, at at scales both in the protein and chemical spaces. Therefore, in addition to to predict drug candidates for a given therapeutic protein target, like more classical ligand-based or receptor-based methods do, chemogenomics can also predict off-targets at the proteome level, and therefore, identify potential side-effects or drug repositioning opportunities. In this study, we study and compare machine-learning and deep learning approaches for chemogenomics, that are applicable to screen large sets of compounds against large sets of druggable proteins. State-of-the-art drug chemogenomics methods rely on expert-based chemical and protein descriptors or similarity measures. The recent development of deep learning approaches enabled to design algorithms that learn numerical abstract representations of molecular graphs and protein sequences in an end-to-end fashion, i.e., so that the learnt features optimise the objective function of the drug-target interaction prediction task. In this paper, we address drug-target interaction prediction at the druggable proteome-level, with what we define as the chemogenomic neuron network. This network consists of a feed-forward neuron network taking as input the combination of molecular and protein representations learnt by molecular graph and protein sequence encoders. We first propose a standard formulation of this chemogenomic neuron network. Then, we compare the performances of the standard chemogenomic network to reference deep learning or shallow (machine-learning without deep learning) methods. In particular, we show that such a representation learning approach is competitive with state-of-the-art chemogenomics with shallow methods, but not ultimately superior. We evaluate the most promising neuron network architectures and data augmentation techniques, such as multi-view and transfer learning, to improve the prediction performance of the chemogenomic network. Our results shed new insights on the design of chemogenomics approaches based on representation learning algorithms. Most importantly, we conclude from our observations that a promising research direction is to integrate heterogeneous sources of data such as various bioactivity datasets, or independently, multiple molecule and protein attribute views, instead of focusing on sophisticated, yet intuitively relevant, encoder’s neuron network architecture.

A fair experimental comparison of neural network architectures for latent representations of multi-omics for drug response prediction

An Innovative Multi-Omics Model Integrating Latent Alignment and Attention Mechanism for Drug Response Prediction

Evaluation of network architecture and data augmentation methods for deep learning in chemogenomics

Comparing high-dimensional neural recordings by aligning their low-dimensional latent representations

Optimal fusion of genotype and drug embeddings in predicting cancer drug response

DeepDRA: Drug repurposing using multi-omics data integration with autoencoders

Interpretable deep learning architectures for improving drug response prediction performance: myth or reality?

Deep-learning: investigating deep neural networks hyper-parameters and comparison of performance to shallow methods for modeling bioactivity data

The application of artificial neural networks in metabolomics: a historical perspective

Deep Learning for Causal Inference: A Comparison of Architectures for Heterogeneous Treatment Effect Estimation

Predictive Multitask Deep Neural Network Models for ADME-Tox Properties: Learning from Large Data Sets

Deep generative neural network for accurate drug response imputation

Data Integration Using Advances in Machine Learning in Drug Discovery and Molecular Biology

Impact of Molecular Representations on Deep Learning Model Comparisons in Drug Response Predictions

Perspectives: Comparison of Deep Learning Segmentation Models on Biophysical and Biomedical Data

An explainable graph neural network approach for effectively integrating multi-omics with prior knowledge to identify biomarkers from interacting biological domains

NeuMF: Predicting Anti-cancer Drug Response Through a Neural Matrix Factorization Model

UNNT: A novel Utility for comparing Neural Net and Tree-based models

Deep learning assisted multi-omics integration for survival and drug-response prediction in breast cancer

Deep latent space fusion for adaptive representation of heterogeneous multi-omics data